Photo of Madina ​Agénor,  ScD, MPH

Madina ​Agénor, ScD, MPH

Harvard T.H. Chan School Of Public Health

Harvard T.H. Chan School Of Public Health


magenor@hsph.harvard.edu

Madina ​Agénor, ScD, MPH

Harvard T.H. Chan School Of Public Health

EDUCATIONAL TITLES

  • Assistant Professor, Social and Behavioral Sciences, Harvard T.H. Chan School Of Public Health

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Madina Agénor, ScD, MPH uses both quantitative and qualitative research methods to investigate and address intersectional inequities in cancer screening and prevention among U.S. adolescents and young adults in relation to sexual orientation, gender, and race/ethnicity. Specifically, Dr. Agénor’s research aims to elucidate and address the multilevel determinants of cervical cancer screening and human papillomavirus (HPV) vaccination among young sexual and gender minorities, with a particular focus on adolescent and young adult lesbian, bisexual, and queer women and transmasculine individuals of color. Her current research uses national probability sample surveys and in-depth interviews to examine how sexual orientation and race/ethnicity singly and simultaneously influence HPV vaccination among U.S. women and girls and surveys, focus groups, and in-depth interviews to understand transmasculine individuals’ access to and experiences with Pap testing, HPV vaccination, and other sexual and reproductive health services.

Publications

Powered by Harvard Catalyst
  • Agénor M, Peitzmeier SM, Bernstein IM, McDowell M, Alizaga NM, Reisner SL, Pardee DJ, Potter J. Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives. Cult Health Sex 2016; 18:1192-206. PubMed
  • Agénor M, Peitzmeier SM, Gordon AR, Charlton BM, Haneuse S, Potter J, Austin SB. Sexual orientation identity disparities in human papillomavirus vaccination initiation and completion among young adult US women and men. Cancer Causes Control 2016; 27:1187-96. PubMed
  • Agénor M, Potter JE, Austin SB. Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine. Ann Intern Med 2015; 163:960-1. PubMed
  • Agénor M, McCauley HL, Peitzmeier SM, Haneuse S, Gordon AR, Potter J, Austin SB. Sex of Sexual Partners and Human Papillomavirus Vaccination Among U.S. Girls and Women. Am J Prev Med 2015. PubMed
  • Agénor M, Peitzmeier S, Gordon AR, Haneuse S, Potter JE, Austin SB. Sexual Orientation Identity Disparities in Awareness and Initiation of the Human Papillomavirus Vaccine Among U.S. Women and Girls: A National Survey. Ann Intern Med 2015; 163:99-106. PubMed
  • Agénor M, Bailey Z, Krieger N, Austin SB, Gottlieb BR. Exploring the Cervical Cancer Screening Experiences of Black Lesbian, Bisexual, and Queer Women: The Role of Patient-Provider Communication. Women Health 2015. PubMed
  • Agénor M, Krieger N, Austin SB, Haneuse S, Gottlieb BR. At the intersection of sexual orientation, race/ethnicity, and cervical cancer screening: assessing Pap test use disparities by sex of sexual partners among black, Latina, and white U.S. women. Soc Sci Med 2014; 116:110-8. PubMed
  • Agénor M, Krieger N, Austin SB, Haneuse S, Gottlieb BR. Sexual orientation disparities in Papanicolaou test use among US women: the role of sexual and reproductive health services. Am J Public Health 2014; 104:e68-73. PubMed